-
Something wrong with this record ?
Modulation of animal and human hematopoiesis by β-glucans: a review
M. Hofer, M. Pospíšil,
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Anemia chemically induced drug therapy MeSH
- beta-Glucans adverse effects pharmacology therapeutic use MeSH
- Hematinics adverse effects pharmacology therapeutic use MeSH
- Hematopoiesis drug effects radiation effects MeSH
- Dosage Forms MeSH
- Humans MeSH
- Antineoplastic Agents adverse effects MeSH
- Radiotherapy adverse effects MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
β-glucans are cell wall constituents of bacteria, yeast, fungi, and plants. They are not expressed in mammalian cells, but they are recognized by mammalian cells as pathogen-associated molecular patterns by pattern recognition receptors and thus act as biological response modifiers. This review summarizes data on the hematopoiesis-stimulating effects of β-glucans, as well as on their ability to enhance bone marrow recovery after an injury. β-glucans have been shown to support murine hematopoiesis suppressed by ionizing radiation or cytotoxic anti-cancer therapy. They also enhance stem cell homing and engraftment. Basically, two forms of β-glucan preparations have been investigated, namely particulate and soluble ones. β-glucans are generally well tolerated, the particulate forms showing a higher incidence of undesirable side effects. Taken together, the hematopoiesis-stimulating properties of β-glucans predetermine these biological response modifiers to ever increasing use in human medicinal practice.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028052
- 003
- CZ-PrNML
- 005
- 20121207123424.0
- 007
- ta
- 008
- 120817e20110915sz f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules16097969 $2 doi
- 035 __
- $a (PubMed)21921869
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hofer, Michal $u Laboratory of Experimental Hematology, Institute of Biophysics, vvi, Academy of Sciences of the Czech Republic, Královopolská 135, CZ-61265 Brno, Czech Republic. hofer@ibp.cz
- 245 10
- $a Modulation of animal and human hematopoiesis by β-glucans: a review / $c M. Hofer, M. Pospíšil,
- 520 9_
- $a β-glucans are cell wall constituents of bacteria, yeast, fungi, and plants. They are not expressed in mammalian cells, but they are recognized by mammalian cells as pathogen-associated molecular patterns by pattern recognition receptors and thus act as biological response modifiers. This review summarizes data on the hematopoiesis-stimulating effects of β-glucans, as well as on their ability to enhance bone marrow recovery after an injury. β-glucans have been shown to support murine hematopoiesis suppressed by ionizing radiation or cytotoxic anti-cancer therapy. They also enhance stem cell homing and engraftment. Basically, two forms of β-glucan preparations have been investigated, namely particulate and soluble ones. β-glucans are generally well tolerated, the particulate forms showing a higher incidence of undesirable side effects. Taken together, the hematopoiesis-stimulating properties of β-glucans predetermine these biological response modifiers to ever increasing use in human medicinal practice.
- 650 _2
- $a anemie $x chemicky indukované $x farmakoterapie $7 D000740
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x škodlivé účinky $7 D000970
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a hematinika $x škodlivé účinky $x farmakologie $x terapeutické užití $7 D006397
- 650 _2
- $a hematopoéza $x účinky léků $x účinky záření $7 D006410
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a radioterapie $x škodlivé účinky $7 D011878
- 650 _2
- $a beta-glukany $x škodlivé účinky $x farmakologie $x terapeutické užití $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pospíšil, Milan
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 16, č. 9 (20110915), s. 7969-79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21921869 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207123458 $b ABA008
- 999 __
- $a ok $b bmc $g 950094 $s 785398
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 16 $c 9 $d 7969-79 $e 20110915 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20120817/11/04